KLK3 and prostate carcinoma: As BFA appears to profoundly down-regulate AR expression, it was of interest to examine whether BFA might also affect other androgen-mediated cellular events (via AR) such as secretion of PSA, which is a useful biomarker for prostate cancer and under the androgenic control [5].